LHCG Set For Nice Growth, Jefferies Reports

After a difficult 2010, Jefferies believes that LHC Group. LHCG is well positioned to adjust to reduced reimbursement levels and benefit from increased consolidation opportunities. “Investor interest is building in the space and is likely to accelerate as good earnings results validate low sector valuations,” Jefferies writes. Reiterate Buy/PT $38 (raised from $32).” Jefferies has raised its PT on LHC Group to $38 from $32. LHC Group closed Tuesday at $29.89.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst RatingsHealth CareHealth Care ServicesJefferiesLHC Group
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!